CBER Plans for Monitoring COVID-19 Vaccine Safety and Effectiveness

Can one be compelled to take a vaccine with the following list of adverse event outcomes provided by the U.S. Food & Drug Administration to the detriment of the safety of every man, woman and child?

Page 16

FDA Safety Surveillance of COVID-19 Vaccines :
DRAFT Working list of possible adverse event outcomes

***Subject to change***

•   Guillain-Barrésyndrome
•   Acute disseminated encephalomyelitis
•   Transverse myelitis
•   Encephalitis/myelitis/encephalomyelitis/ meningoencephalitis/meningitis/ encepholapathy
•   Convulsions/seizures
•   Stroke
•   Narcolepsy and cataplexy
•   Anaphylaxis
•   Acute myocardial infarction
•   Myocarditis/pericarditis
•   Autoimmune disease

•   Deaths
•   Pregnancy and birth outcomes
•   Other acutede myelinating diseases
•   Non-anaphylacticallergicreactions
•   Thrombocytopenia
•   Disseminated intravascular coagulation
•   Venous thromboembolism
•   Arthritis and arthralgia/joint pain
•   Kawasaki disease
•   Multisystem Inflammatory Syndrome in Children
•   Vaccine enhanced disease